Chu Poitiers — Poitiers

Public research footprint of Chu Poitiers, compiled from the ClinicalTrials.gov public registry.

441

Registered studies

180

Active

110

Recruiting now

193

Completed

Stopped or withdrawn

Most-studied conditions

Squamous Non Small Cell Lung Cancer (NSCLC-SCC) · Renal Cell Carcinoma (Kidney Cancer) · Triple Negative Breast Cancer · Solid Tumor, Adult

Recently updated registry entries

NCT05702034 — A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk… (Active Not Recruiting)
NCT03888105 — A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients… (Active Not Recruiting)
NCT04557098 — A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Chu Poitiers?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.